Ana M. Dias

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease.

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: March 15, 2025

A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan.

A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan.

Journal: Nature immunology

Published: June 28, 2023

Mannosylated glycans impair normal T-cell development by reprogramming commitment and repertoire diversity.

Mannosylated glycans impair normal T-cell development by reprogramming commitment and repertoire diversity.

Journal: Cellular & molecular immunology

Published: November 09, 2022

Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player.

Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player.

Journal: Inflammatory bowel diseases

Published: March 03, 2021

SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.

SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: February 12, 2021

Composition of the immunoglobulin G glycome associates with the severity of COVID-19.

Composition of the immunoglobulin G glycome associates with the severity of COVID-19.

Journal: Glycobiology

Published: October 18, 2020

Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases.

Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases.

Journal: Gastroenterology

Published: May 09, 2019

A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients.

A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients.

Journal: Journal of Crohn's & colitis

Published: September 22, 2018

Metabolic control of T cell immune response through glycans in inflammatory bowel disease.

Metabolic control of T cell immune response through glycans in inflammatory bowel disease.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 04, 2018

Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease.

Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease.

Journal: Clinical epigenetics

Published: February 28, 2018

Studying T Cells N-Glycosylation by Imaging Flow Cytometry.

Studying T Cells N-Glycosylation by Imaging Flow Cytometry.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 28, 2016

Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis.

Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis.

Journal: Human molecular genetics

Published: December 17, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026